Modulation of Gut Microbiota by Probiotic in Children

Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age1-7
SponsorMin-Tze LIONG

About this trial

This project aims to study the benefits of probiotics namely Bifidobacterium infantis YLGB-1496 in modulating gut microbiota of healthy children, among pre-school children in Malaysia \<7 years old.

Eligibility criteria

Qualifiers

Preschool children (<7 years old)

Born full-term (≥37 weeks delivered)

In generally good health as determined by the investigator

Disqualifiers

Had taken probiotics or prebiotics within past 4-weeks

Had taken milk powder or supplements containing probiotics within past 4-weeks

History of using antibiotic within past 4-weeks

Suffering from serious acute or chronic diseases (cardiovascular disease, gastrointestinal disease, endocrine disease, immune system disease, metabolic disease, etc.)

Trial design

Treatments tested in this trial

  • Probiotic
  • Placebo

Treatment groups

120 Participants
are divided into 2 treatment groups

Locations

1

Map coordinates are unavailable for these locations. Locations are shown below instead.

UKM Medical CentreRecruiting56000, Cheras, Kuala LumpurMalaysiaMalaysia

Sponsors and collaborators

Min-Tze LIONG

Lead sponsor

Universiti Sains Malaysia

Sponsor institution

National University of Malaysia

Collaborator